P53 mutations in hairy cell leukemia

Leukemia

Volumn 14, Issue 4, 2000, Pages 706-711

  Konig E A ^a,b   Kusser, W C ^b   Day, C ^b   Porzsolt, F ^d   Glickman, B W ^b   Messer, G ^d   Schmid, M ^d   De Chatel R ^a   Marcsek, Z L ^a   Demeter, J ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF VICTORIA   (Canada)

^c SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^d NONE

Author keywords

Hairy cell leukemia; Mutation; P53

Indexed keywords

ALPHA INTERFERON; PROTEIN P53;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BLOOD CELL; CANCER GENETICS; CANCER SURVIVAL; CODON; CONTROLLED STUDY; DNA DETERMINATION; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SPLEEN CELL; SURVIVAL TIME;

EID: 0343133863     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401721     Document Type: Article

References (40)

1. Burthem J, Cawley JC. Hairy-Cell Leukemia. Springer: London, 1996
2. Grever M, Kopeczky K, Foucar MK, Head D, Bennet JM, Hutchison JM, Corbett RE, Cassileth PA, Habermann T, Golomb H, Rai K, Eisenhauer E, Appelbaum F, Cheson BD. Randomized comparison of pentostatin vs interferon-alfa2a in previously untreated patients with hairy cell leukemia: an intergroup study. J Clin Oncol 1995; 13: 974-982.
3. Piro LD, Carrera CJ, Carson DA, Beutler JE. Lasting remission in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxy-adenosine. New Engl J Med 1990; 322: 1117-1121.
4. Tallman MS, Hakimian D, Kopecky KJ, Wheaton S, Wollins E, Foucar K, Cassileth PA, Habermann T, Grever M, Rowe JM, Peterson LC. Minimal residual disease in patient with hairy cell leukaemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. Clin Cancer Res 1999; 7: 1665-1670.
5. Kampmeier P, Spielberger R, Dickstein J, Mick R, Golomb H, Vardiman JW. Increased incidence of second neoplasms in patients treated with interferon alpha 2b for hairy cell leukemia: a clinicopathologic assessment. Blood 1994; 83: 2931-2938.
6. Prokocimer M, Rotter V. Structure and function of the p53 in normal cells and their aberration in cancer cells: projection on the hematologic cell lineages. Blood 1994; 84: 2391-2411.
7. Preudhomme C, Fenaux P. The clinical significance of mutations of the p53 suppressor gene in haematological malignancies. Br J Haematol 1997; 98: 502-511.
8. Lynch SA, Brugge JS, Fromowitz F, Glantz L, Wang P, Caruso R, Viola MV. Increased expression of the src proto-oncogene in hairy cell leukemia and a subgroup of B cell lymphomas. Leukemia 1993; 7: 1416-1422.
9. Bosch F, Campo E, Jares P, Pittaluga S, Munoz J, Nayach I, Piris MA, Dewolf-Peeters C, Jaffe ES, Rozman C, Montserrat E, Cardesa A. Increased expression of the PRAD-1/CCND1 gene in hairy cell leukaemia. Br J Haematol 1995; 91: 1025-1030.
10. Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poustka A, Hunstein W, Lichter P. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995; 85: 1580-1589.
11. Greiner TC, Moynihan MJ, Chan WC, Lytle DM, Pedersen A, Anderson JR, Weisenburger DD. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996; 87: 4302-4310.
12. Hernandez L, Fest T, Cazorla M, Teruya-Feldstein J, Bosch F, Peinado MA, Piris MA, Montserrat E, Cardesa A, Jaffe ES, Campo E, Raffeld M. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood 1996; 87: 3351-3359.
13. Lens D, Dyer MJS, Garcia-Marco JM, de Schouwer PJJC, Hamoudi RA, Jones D, Farahat N, Matutes E, Catovsky D. p53 abnormalities in CLL are associated with excess of prolymphocytes and poor prognosis. Br J Haematol 1997; 99: 848-857.
14. Ichikawa A, Kinoshita T, Watanabe T, Kato H, Nagai H, Tsushita K, Saito H, Hotta T. Mutations of the p53 gene as a prognostic factor in aggressive B cell lymphoma. New Engl J Med 1997; 337: 529-534.
15. Marcsek ZL, König EA. Accumulating mutations of p53 in colon tumor and in hairy cell leukemia do not arise from methylation/deamination processes, but rather from nucleotide deletions and insertions. Biol Chem 1998; 379: 545-547.
16. Murakami Y, Hayashi K, Sekiya T. Detection of aberration of the p53 alleles and the gene transcript in human cell lines by single-strand conformation polymorphism analysis. Cancer Res 1991; 51: 3356-3361.
17. Serra A, Gaidano GL, Revello D, Guerrasio A, Ballerini P, Dalla Favera R, Saglio G. A new Taq I polymorphism in the p53 gene. Nucleic Acids Res 1992; 20: 928.
18. Kusser WC, Miao X, Glickman BW, Friedland JM, Rothman N, Hemstreet GP, Mellot J, Swan DC, Schulte PA, Hayes R. p53 mutations in human bladder cancer. Environ Mol Mutagen 1994; 24: 156-160.
19. Hongyo T, Buzard GS, Calvert RJ, Weghorst CM. 'Cold SSCP': a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses. Nucleic Acids Res 1993; 21: 3637-3642.
20. Sugano K, Kyogoku A, Fukayama N, Ohkura H, Shimosato Y, Sekiya T, Hayashi K. Rapid and simple detection of c-Ki-ras2 gene codon 12 mutations by nonradioisotopic single-strand conformation polymorphism analysis. Lab Invest 1993; 68: 361-366.
21. Switzer RC, Merril CR, Shifrin S. A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem 1979; 98: 231-237.
22. Dearden CE, Matutes E, Hilditch BL, Swansbury GJ, Catovsky D. Long-term follow-up of patients with hairy-cell leukaemia after treatment with pentostatin or cladribine. Br J Haematol 1999; 106: 515-519.
23. Saven A, Burian C, Koziol JA, Piro LD. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment. Blood 1998; 92: 1918-1926.
24. Diez-Martin JL, Li CY, Banks PM. Blastic variant of hairy-cell leukemia. Am J Clin Pathol 1987; 87: 576-583.
25. Nazeer T, Burkart P, Dunn H, Jennings TA, Wolf B. Blastic transformation of hairy cell leukemia. Arch Pathol Lab Med 1997; 121: 707-713.
26. Eckert KA, Kunkel TA. DNA polymerase fidelity and the polymerase chain reaction. PCR-Meth Appl 1991; 1: 17-24.
27. Fenaux P, Preudhomme C, Lai JL, QuiQuandon I, Jonveaux PH, Vanrumbeke M, Loucheux-Lefebvre MH, Bauters F, Berger R, Kerckaert K. Mutations of the p53 gene in B cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 1992; 6: 246-250.
28. El-Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, Newcomb EW. p53 gene mutation in B-cell chronic leukemia is associated with drug resistance and is independent of MDR1-MDR3 gene expression. Blood 1993; 82: 3452-3459.
29. Cordone I, Masi S, Mauro FR, Soddu S, Morsilli O, Valentini T, Vegna ML, Guglielmi C, Mancini F, Giuliacci S, Sacchi A, Mandelli F, Foa R. p53 expression in B cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis. Blood 1998; 91: 4342-4349.
30. Lens D, de Schouver PJJC, Hamoudi RA, Abdul-Rauf M, Farahat N, Matutes E, Crook T, Dyer MJS, Catovsky D. p53 abnormalities in B cell prolymphocytic leukemia. Blood 1997; 89: 2015-2023.
31. Neri A, Baldini L, Trecca D, Cro L, Polli E, Maiolo AT. p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 1993; 81: 128-135.
32. Preudhomme C, Facon T, Zandecki M, Vanrumbeke M, Lai JL, Nataf E, Loucheux-Lefebvre MH, Kerckaert JP, Fenaux P. Rare occurrence of p53 mutations in multiple myeloma. Br J Haematol 1992; 81: 440-443.
33. Schmid M, Schrezenmeier H, Staib G, Porzsolt F. Evidence for a paracrine pathway of B-cell stimulation in hairy cell leukaemia. Br J Haematol 1995; 90: 156-162.
34. Kluin-Nelemans JC, Kester MC, Melenhorst JJ, Landegent JE, van de Corput L, Willemze R, Falkenburg JF. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukaemia. Blood 1996; 87: 3795-3802.
35. Van den Corput L, Falkenburg JH, Kluin-Nelemans JC. T-cell dysfunction in hairy cell leukaemia: an updated review. Leuk Lymphoma 1998; 30: 31-39.
36. Haglund U, Juliusson G, Stellan B, Gahrton G. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood 1994; 83: 2637-2645.
37. Wu X, Merup M, Juliusson G, Jansson M, Stellan B, Grander D, Zabarovsky E, Liu Y, Spasokoukotskaja T, Gahrton G, Einhorn S. Characterization of a hairy cell leukemia-associated 5q13.3 inversion breakpoint. Genes Chromos Cancer 1997; 20: 337-346.
38. + marker in hairy cell leukemia. A cytogenetic study of 15 cases. Leukemia Res 1986; 10: 131-138.
39. Vallinatou K, Brito-Babapulle V, Matutes E, Atkinson S, Catovsky D. P53 allele deletion and trisomy 12 in hairy cell leukaemia (HCL) and hairy cell leukaemia variant (HCL-V). Clinicopathologic correlations. Blood 1998; 92 (Suppl. 1): 226a-227a.
40. Brito-Babapulle V, Matutes E, Oscier D, Mould S, Catovsky D. Chromosome abnormalities in hairy cell leukemia variant. Genes Chromos Cancer 1994; 10: 197-202.